Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/1999
03/18/1999WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999WO1999013092A1 Enhancement of mucosal antibody responses by interleukin-6
03/18/1999WO1999013084A1 Group a streptococcal vaccines
03/18/1999WO1999013078A1 Cysteine rich receptors-train
03/18/1999WO1999013057A1 CLASS I-TYPE LYSYL-tRNA SYNTHETASE
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999013053A1 Genetically modified tumor-targeted bacteria with reduced virulence
03/18/1999WO1999012974A1 Monoclonal antibodies that bind testosterone
03/18/1999WO1999012973A1 Monoclonal antibody inducing apoptosis
03/18/1999WO1999012971A2 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
03/18/1999WO1999012965A2 April- a novel protein with growth effects
03/18/1999WO1999012964A2 Kay - a novel immune system protein
03/18/1999WO1999012963A2 Cysteine rich receptors: trail
03/18/1999WO1999012960A2 P13 ANTIGENS FROM $i(BORRELIA)
03/18/1999WO1999012959A1 Carbohydrate crosslinked glycoprotein crystals
03/18/1999WO1999012640A1 Coated particles, methods of making and using
03/18/1999WO1999012584A1 Methods for inhibiting rejection of transplanted tissues by bone grafting
03/18/1999WO1999012574A1 Improvements in or relating to expression of immunogenic substances
03/18/1999WO1999012573A1 Improvements in or relating to regulation of t cell activation
03/18/1999WO1999012568A1 Stabilizers containing recombinant human serum albumin for live virus vaccines
03/18/1999WO1999012567A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012565A1 Vaccines
03/18/1999WO1999012564A1 Bovine footrot treatment and prevention
03/18/1999WO1999012563A2 Mucosal cytotoxic t lymphocyte responses
03/18/1999WO1999012562A1 Synthetic antigens for cd1-restricted immune responses
03/18/1999WO1999012556A1 HIV-1 gp120 V1/V2 DOMAIN EPITOPES CAPABLE OF GENERATING NEUTRALIZING ANTIBODIES
03/18/1999WO1999012553A1 Methods for producing human antibodies in scid mice using dendritic cells
03/18/1999WO1999000490A3 Attenuated human immunodeficiency virus vaccine
03/18/1999WO1999000410A3 Human extracellular matrix proteins
03/18/1999WO1998058956A3 Methods for inducing an immune response involving prime-boost protocols
03/18/1999WO1998058954A3 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
03/18/1999WO1998058953A3 Surface exposed proteins from chlamydia pneumoniae
03/18/1999WO1998057672A3 Process for reducing the concentration of viral and molecular pathogens in a biological material
03/18/1999WO1998056901A3 Live attenuated vaccines
03/18/1999DE19740735A1 Antibodies specific for Borrelia burgdorferi 24 kD antigen OspC
03/18/1999DE19740357A1 New sugar phosphate compounds
03/18/1999DE19740092A1 New liposome comprises lipid envelope based on natural or synthetic skin
03/18/1999DE19738710A1 A novel T-cell transmembrane protein (TIRC7)
03/18/1999CA2303618A1 Improvements in or relating to expression of immunogenic substances
03/18/1999CA2303617A1 Improvements in or relating to regulation of t cell activation
03/18/1999CA2303615A1 April- a novel protein with growth effects
03/18/1999CA2303486A1 Stabilization of helicobacter urease
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303424A1 Kay - a novel immune system protein
03/18/1999CA2303410A1 Mucosal cytotoxic t lymphocyte responses
03/18/1999CA2303409A1 Class i-type lysyl-trna synthetase
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999CA2303072A1 Monoclonal antibody inducing apoptosis
03/18/1999CA2303008A1 Methods for inhibiting rejection of transplanted tissues by bone grafting
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302637A1 Vaccine compositions comprising an oil/water emulsion with saponin and sterol
03/18/1999CA2302282A1 Stabilizers containing recombinant human serum albumin for live virus vaccines
03/18/1999CA2302155A1 Synthetic antigens for cd1-restricted immune responses
03/18/1999CA2301979A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999CA2301173A1 Cysteine rich receptors-train
03/18/1999CA2300958A1 Bovine footrot treatment and prevention
03/18/1999CA2300804A1 Monoclonal antibodies that bind testosterone
03/18/1999CA2300365A1 P13 antigens from borrelia
03/18/1999CA2244325A1 Novel amps
03/18/1999CA2244323A1 Novel gapdh
03/18/1999CA2244241A1 Novel phoh
03/17/1999EP0902087A2 Histidine kinase
03/17/1999EP0902086A1 Tuberculosis vaccine
03/17/1999EP0901530A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
03/17/1999EP0901526A1 Cortistatin: neuropeptides, compositions and methods
03/17/1999EP0901521A1 Antigenic modulation of cells
03/17/1999EP0901375A1 Dhea combination therapy
03/17/1999EP0901370A1 Stimulation of immune response with low doses of il-2
03/17/1999EP0740792B1 Peptomers with enhanced immunogenicity
03/17/1999EP0733065B1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
03/17/1999EP0728148B1 Improved immunogenic compositions against human gastrin 17
03/17/1999EP0616613B1 Fragments of prion proteins
03/17/1999EP0616536B1 Use of decorin or biglycan for the manufacture of a medicament in the treatment of diabetes-associated pathology
03/17/1999EP0614465B1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG
03/17/1999EP0558631B1 Recombinant avirulent salmonella antifertility vaccines
03/17/1999CN1211279A Composition and methods for the treatment and diagnosis of breast cancer
03/17/1999CN1211255A Ob receptor and method of diagnosing and treating weight
03/17/1999CN1211192A Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
03/17/1999CN1210740A Oil adjuvant inactivated vaccine for newcastle disease and its preparing method
03/17/1999CA2244330A1 Novel histidine kinase
03/16/1999US5883239 aroA
03/16/1999US5883227 Multiple sclerosis associated polypeptide
03/16/1999US5883225 Polypeptides and sequence
03/16/1999US5883224 Characterization of transfer factors and methods of use
03/16/1999US5883082 Compositions and methods for preventing and treating allograft rejection
03/16/1999US5882945 Isolation, expression, immunizing and antibodies
03/16/1999US5882901 Sialylating specified oligosaccharide with sialyltransferase, fucosylating with fucosyltransferase
03/16/1999US5882898 Cells and vectors with polynucleotides
03/16/1999US5882897 yitJ
03/16/1999US5882896 M protein
03/16/1999US5882894 Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof
03/16/1999US5882892 Polypeptides and dna(rna) encoding and screening for bactericides
03/16/1999US5882891 Polynucleotide segments
03/16/1999US5882889 Response regulator in a two component signal transduction system
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882876 Amino acid sequences in proteins and markers of cancer cells
03/16/1999US5882871 Saliva binding protein
03/16/1999US5882853 Culture of t-cells for patients to form polypeptides
03/16/1999US5882852 Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
1 ... 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 ... 1823